Further supporting the results from our murine experiments, we also observed a significant positive correlation between CCL2 and CCL7 expression and markers of TAMs, including AIF1, CD163, MRC1, and CCR2, in human GBM (Fig. S8A). This evidence concerns the gene CCR2 and glioblastoma.